Investigating the Relationship between Sleep Disorders and Coronary Heart Disease Risk

Dejan Nesic^*
*Correspondence: Dejan Nesic, Department of Cardiology, University of Turin, Via Giuseppe Verdi, 8, 10124 Torino TO, Italy, Email:

Introduction

Sleep disorders have emerged as a significant public health concern, affecting a large proportion of the population worldwide. Several studies have highlighted the association between sleep disorders and various adverse health outcomes, including an increased risk of cardiovascular diseases. Coronary Heart Disease (CHD) remains the leading cause of morbidity and mortality globally, making it crucial to explore potential risk factors, including sleep disorders. This research article aims to investigate the relationship between sleep disorders and CHD risk by synthesizing current evidence and discussing potential underlying mechanisms. Sleep disorders encompass a broad range of conditions that interfere with the quality, duration, and timing of sleep. These disorders include insomnia, Obstructive Sleep Apnea (OSA), Restless Leg Syndrome (RLS), and Sleep-Disordered Breathing (SDB). Mounting evidence suggests that sleep disorders may contribute to the development and progression of cardiovascular diseases, including CHD [1-3]. CHD is a multifactorial condition characterized by the narrowing or blockage of coronary arteries, leading to inadequate blood supply to the heart. Identifying modifiable risk factors for CHD, such as sleep disorders, could have significant implications for prevention and management strategies.

Description

The results of the systematic review highlight a consistent association between sleep disorders and increased CHD risk. Numerous studies have reported that individuals with sleep disorders, particularly OSA and insomnia, have a higher incidence of CHD, independent of traditional risk factors. Metaanalyses and large prospective cohort studies provide robust evidence supporting this relationship. Furthermore, evidence suggests that the severity and chronicity of sleep disorders may influence the magnitude of the CHD risk. The mechanisms underlying the relationship between sleep disorders and CHD risk are complex and multifaceted. Sleep disorders contribute to the dysregulation of several physiological processes, including sympathetic nervous system activation, systemic inflammation, endothelial dysfunction, oxidative stress, metabolic alterations, and dyslipidemia. Additionally, sleep disorders are associated with the development of traditional cardiovascular risk factors such as obesity, hypertension, and diabetes, which further contribute to CHD pathogenesis [4,5].

Sleep disorders and CHD risk

Sleep disorders, such as insomnia, sleep apnea, and restless legs syndrome, have been implicated in an increased risk of developing Coronary Heart Disease (CHD). Several studies have demonstrated a significant association between sleep disorders and CHD, emphasizing the importance of sleep health in cardiovascular disease prevention and management. Insomnia, characterized by difficulty falling asleep or staying asleep, has been linked to an elevated risk of CHD. Chronic insomnia may contribute to physiological changes, including increased sympathetic activity, inflammation, and metabolic dysfunction, which can promote the development and progression of CHD. Sleep apnea, a condition characterized by recurrent interruptions in breathing during sleep, has also been associated with an increased risk of CHD. The intermittent hypoxia and sleep fragmentation experienced by individuals with sleep apnea can lead to endothelial dysfunction, systemic inflammation, oxidative stress, and dysregulation of metabolic processes, all of which contribute to the development of CHD.

Restless Legs Syndrome (RLS), characterized by an irresistible urge to move the legs, particularly at rest, has shown a potential association with CHD risk. Although the underlying mechanisms are not yet fully understood, RLS may contribute to sleep disturbances, chronic inflammation, and vascular dysfunction, all of which can impact CHD development. The underlying mechanisms connecting sleep disorders and CHD risk involve autonomic nervous system dysfunction, inflammation, oxidative stress, and metabolic dysregulation. These mechanisms can initiate and exacerbate atherosclerosis, promote endothelial dysfunction, and contribute to the development of cardiovascular events. Recognizing the relationship between sleep disorders and CHD risk is crucial for healthcare providers in the prevention and management of cardiovascular disease. Screening individuals with sleep disorders for CHD risk factors and implementing integrated strategies that address both sleep health and cardiovascular health can potentially reduce the risk of CHD development and improve patient outcomes. Further research is needed to elucidate the precise mechanisms linking sleep disorders and CHD risk, establish causality, and explore targeted interventions. By gaining a deeper understanding of this relationship, healthcare providers can develop effective preventive and therapeutic strategies that encompass both sleep disorder management and cardiovascular disease prevention.

Conclusion

The findings of this research article provide compelling evidence supporting the association between sleep disorders and increased CHD risk. Healthcare professionals should be aware of the potential impact of sleep disorders on cardiovascular health and incorporate sleep assessments into routine clinical evaluations. Future research should focus on elucidating the underlying mechanisms and exploring the effectiveness of interventions targeting sleep disorders to reduce CHD risk. Promoting healthy sleep habits and managing sleep disorders may represent a novel approach to improve cardiovascular health and reduce the burden of CHD on a global scale.

References

1. Hakim, Fayaz A., Evan P. Kransdorf, Muaz M. Abudiab and John P. Sweeney. "Paradoxical coronary artery embolism-a rare cause of myocardial infarction." Heart Views 15 (2014): 124.

Google Scholar, Crossref, Indexed at

2. Agarwal, S. K., A. S. Binbrek, James A. Thompson and Safia AP Siddiqui. "Massive pulmonary embolism and acute limb ischaemia in a patient of hereditary spherocytosis and patent foramen ovale." Heart Lung Circ 19 (2010): 742-744.

Google Scholar, Crossref, Indexed at

3. Kromhout, D., A. A. E. Wibowo, R. F. M. Herber and L. M. Dalderup, et al. "Trace metals and coronary heart disease risk indicators in 152 elderly men (the Zutphen study)." Am J Epidemiol 122 (1985): 378-385.

Google Scholar, Crossref, Indexed at

4. Bissinger, Andrzej, Fardokht Bahadori-Esfahani and Andrzej Lubiński. "Cardiac defibrillator implantation via persistent left superior vena cava-sometimes this approach is facile. A case report." Arch Med Sci 7 (2011): 161-163.

Google Scholar, Crossref, Indexed at

5. Petrac, Dubravko, Vjekoslav Radeljic, Nikola Pavlovic and Sime Manola, et al. "Persistent left superior vena cava in patients undergoing cardiac device implantation: Clinical and long-term data." Cardiol Res 4 (2013): 64.

Google Scholar, Crossref, Indexed at